News
Last Patient Out: MetrioPharm Completes Clinical Phase II Trial in COVID-19
August 8, 2022
Last Patient Out: MetrioPharm Completes Clinical Phase II Trial in COVID-19 The last patient had his/her last visit in MetrioPharm’s trial in COVID-19 on July
MetrioPharm partakes in EU-wide coordination and collaboration meeting for EU-funded projects conducting clinical trials on COVID-19 therapeutics
May 3, 2022
MetrioPharm partakes in EU-wide coordination and collaboration meeting for EU-funded projects conducting clinical trials on COVID-19 therapeutics Virtual meeting, April 06, 2022 We are
MetrioPharm surpasses 50% of enrollment in Phase II study in COVID-19
April 11, 2022
MetrioPharm surpasses 50% of enrollment in Phase II study in COVID-19 Zurich, March 02, 2022. MetrioPharm AG, a pharmaceutical company developing drugs for inflammatory
MetrioPharm Signs European Commission Grant Agreement for €7.9 Million
January 20, 2022
MetrioPharm Signs European Commission Grant Agreement for €7.9 Million European commission funds COVID project iMPact with 7.9 million euros MetrioPharm will receive a total of
Vacancies
No vacancies at this time
